These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 12592325
1. Imatinib mesylate (STI571) in preparation for allogeneic hematopoietic stem cell transplantation and donor lymphocyte infusions in patients with Philadelphia-positive acute leukemias. Shimoni A, Kröger N, Zander AR, Rowe JM, Hardan I, Avigdor A, Yeshurun M, Ben-Bassat I, Nagler A. Leukemia; 2003 Feb; 17(2):290-7. PubMed ID: 12592325 [Abstract] [Full Text] [Related]
4. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4.5-year follow-up. Lahaye T, Riehm B, Berger U, Paschka P, Müller MC, Kreil S, Merx K, Schwindel U, Schoch C, Hehlmann R, Hochhaus A. Cancer; 2005 Apr 15; 103(8):1659-69. PubMed ID: 15747376 [Abstract] [Full Text] [Related]
5. Imatinib mesylate (STI-571) given concurrently with nonmyeloablative stem cell transplantation did not compromise engraftment and resulted in cytogenetic remission in a patient with chronic myeloid leukemia in blast crisis. Koh LP, Hwang WY, Chuah CT, Linn YC, Goh YT, Tan CH, Ng HJ, Tan PH. Bone Marrow Transplant; 2003 Feb 15; 31(4):305-8. PubMed ID: 12621468 [Abstract] [Full Text] [Related]
6. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment. Simon W, Segel GB, Lichtman MA. Blood Cells Mol Dis; 2006 Feb 15; 37(2):116-24; discussion 125-7. PubMed ID: 16904348 [Abstract] [Full Text] [Related]
7. [Allogeneic stem cell transplantation for patients with Philadelphia positive leukemia resistant to imatinib]. Han W, Liu KY, Xu LP, Chen H, Liu DH, Chen YH, Zhang XH, Zhang YC, Chen Y, Wang Y, Wang J, Lu DP, Huang XJ. Zhonghua Yi Xue Za Zhi; 2008 Jul 22; 88(28):1974-7. PubMed ID: 19062738 [Abstract] [Full Text] [Related]
8. The extent of minimal residual disease reduction after the first 4-week imatinib therapy determines outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia. Lee S, Kim YJ, Chung NG, Lim J, Lee DG, Kim HJ, Min CK, Lee JW, Min WS, Kim CC. Cancer; 2009 Feb 01; 115(3):561-70. PubMed ID: 19117346 [Abstract] [Full Text] [Related]
9. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Burke MJ, Cao Q, Trotz B, Weigel B, Kumar A, Smith A, Verneris MR. Pediatr Blood Cancer; 2009 Dec 15; 53(7):1289-94. PubMed ID: 19731318 [Abstract] [Full Text] [Related]
13. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation. Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N. Bone Marrow Transplant; 1997 Oct 15; 20(7):533-41. PubMed ID: 9337054 [Abstract] [Full Text] [Related]
14. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH. Biol Blood Marrow Transplant; 2004 Mar 15; 10(3):204-12. PubMed ID: 14993886 [Abstract] [Full Text] [Related]
15. Successful interim therapy with imatinib prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute myeloid leukemia. Cho BS, Kim HJ, Lee S, Eom KS, Min WS, Lee JW, Kim CC. Eur J Haematol; 2007 Aug 15; 79(2):170-3. PubMed ID: 17608710 [Abstract] [Full Text] [Related]